Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2012
03/07/2012EP2424894A1 Composition and methods of use for therapeutic antibodies specific for the il-12 receptore betal subunit
03/07/2012EP2424893A2 Pharmaceutical agent
03/07/2012EP2424892A2 Dc-stamp antibodies
03/07/2012EP2424890A2 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
03/07/2012EP2424884A1 A novel subtype of clostridium botulinum neurotoxin type a and uses thereof
03/07/2012EP2424879A1 Influenza vaccine
03/07/2012EP2424566A2 Dual variable domain immunoglobulins and uses thereof
03/07/2012EP2424565A1 Adjuvanted vaccines for protecting against influenza
03/07/2012EP2424564A1 Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
03/07/2012EP2424563A2 Chimeric factor h binding proteins (fhbp) and methods of use
03/07/2012EP2424562A1 Pneumococcal vaccine and uses thereof
03/07/2012EP2424560A1 Compounds and methods for modulating an immune response
03/07/2012EP2129391B1 Diagnostic method
03/07/2012EP2047256B1 A method for the in vitro screening of anti-cancer compounds that inhibits sk3 activity, and said anti-cancer compounds
03/07/2012EP1961767B1 Diagnosis and treatment of cancers and other conditions
03/07/2012EP1868645B1 Multivalent pneumococcal polysaccharide-protein conjugate composition
03/07/2012EP1730197B1 Methods for inducing autolysis in infectious bacteria
03/07/2012EP1713907B1 Hybrid proteins of active-site serine beta-lactamase.
03/07/2012EP1583506B1 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
03/07/2012EP1355923B1 Immunomodulatory peptides derived from heat shock proteins and uses thereof
03/07/2012CN102369242A Polyion complex comprising hydrophobized polyamino acid and use of same
03/07/2012CN102369219A Antibodies against human tweak and uses thereof
03/07/2012CN102369218A Anti-fcrh5 antibodies and immunoconjugates and methods of use
03/07/2012CN102369217A Il-1 binding proteins
03/07/2012CN102369216A Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same
03/07/2012CN102369214A Trivalent, bispecific antibodies
03/07/2012CN102369021A Covalent diabodies and uses thereof
03/07/2012CN102367277A Polymer conjugates of mutated neublastin
03/07/2012CN102366630A Polysaccharide-staphylococcal surface adhesion carrier protein conjugates for immunization against nosocomial infections
03/07/2012CN102366629A Freshwater fish aeromonas hydrophila-aeromonas sobria bivalent inactivated vaccine and industrialized preparation method thereof
03/07/2012CN101843902B Method for preparing polyvalent antiserum for resisting venin of common terrestrial viperidae venomous snakes in China and application thereof
03/07/2012CN101397332B Functional peptide section of epididymis protease inhibitors and multiple antigenic peptide constructed thereby
03/07/2012CN101116744B Combination neisserial compositions
03/06/2012US8129518 Synthetic polysaccharide antigens for immunological intervention in disease
03/06/2012US8129506 Modulation of the interaction of MUC1 with MUC1 ligands
03/06/2012US8129502 Monoclonal antibody produced by hybridoma with IDAC accession number 180706-02; competitive binding of monoclonal antibody, humanized-, chimeric- or cancerous disease modifying antibodies (CDMAB) with tissue sample induces cytotoxicity; anticarcinogenic, antitumor, and antimetastasis agents; diagnosis
03/06/2012US8129500 Porphyromonas gingivalis polypeptides and nucleotides
03/06/2012US8129499 Antiviral peptides against influenza virus
03/06/2012US8129351 for treatment of atopic conditions (dermatitis, allergies) and influenza virus; point mutations
03/06/2012US8129333 Antigen delivery vectors and constructs
03/06/2012US8129183 Method for stimulating dendritic cells and cell product thus obtained for the autologous immunotherapy of solid human tumours
03/06/2012US8129167 UL16 binding protein 4
03/06/2012US8129165 Borrelia antigens
03/06/2012US8129147 Meningococcal oligosaccharide linked polysaccharides and diptheria protein conjugate vaccine for all ages
03/06/2012US8129114 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
03/06/2012US8128943 Use of oxazole derivatives for controlling fish parasites
03/06/2012US8128942 Anti-sepsis conjugate vaccine
03/06/2012US8128941 Assay for detecting tuberculosis in nonhuman primates
03/06/2012US8128939 Mutants of cholesterol-dependent cytolysins and uses thereof
03/06/2012US8128938 Influenza virus vaccine composition and methods of use
03/06/2012US8128937 N protein mutants of porcine reproductive and respiratory syndrome virus
03/06/2012US8128936 Immunogenic compositions for Streptococcus pyogenes
03/06/2012US8128935 DNA sequence and recombinant production of the grass pollen allergen Phl p 4
03/06/2012US8128934 Method for treatment or prevention of disease associated with functional disorder of regulatory T cell
03/06/2012US8128933 Method of promoting bone growth by an anti-activin B antibody
03/06/2012US8128932 Anti-VEGFR monoclonal antibody, method of making and uses thereof
03/06/2012US8128931 native staphylococcal enterotoxin or streptococcal pyrogenic exotoxin protein, stimulates T cell mitogensis; fusion proteins; carcinomas; combination therapy
03/06/2012US8128930 Anti-ADDL antibodies and uses thereof
03/06/2012US8128929 Antibodies against PDGFRa
03/06/2012US8128928 Humanized antibodies that recognize beta amyloid peptide
03/06/2012US8128927 Methods of using TGF-β 1 binding compositions
03/06/2012US8128926 Sp35 antibodies and uses thereof
03/06/2012US8128922 Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
03/06/2012US8128921 Use of conditional plasmodium strains lacking nutrient transporters in malaria vaccination
03/06/2012CA2657491C Vaccines
03/06/2012CA2593122C Anti a beta antibody formulation
03/06/2012CA2483707C Microparticles bearing cells and active substances
03/06/2012CA2480666C Tnp-470 polymer conjugates and use thereof
03/06/2012CA2470579C Production of f(ab')2 fragments in mammalian cells
03/06/2012CA2452008C Ltb4 as vaccine adjuvant
03/06/2012CA2445664C Use of il-18 inhibitors for treating or preventing cns injuries
03/06/2012CA2392880C Compositions comprising neisseria meningitidis antigens from serogroups b and c
03/06/2012CA2370697C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
03/06/2012CA2290944C Pgc-1, a novel brown fat ppar.gamma. coactivator
03/06/2012CA2253924C Vasoactive amine binding molecules
03/06/2012CA2202408C Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
03/01/2012WO2012027745A1 Treatment of renal diseases
03/01/2012WO2012027723A1 Notum protein modulators and methods of use
03/01/2012WO2012027721A2 Antibodies to matrix metalloproteinase 9
03/01/2012WO2012027611A2 INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES
03/01/2012WO2012027570A2 Dual variable domain immunoglobulins and uses thereof
03/01/2012WO2012027555A2 Glycated cd59 peptides, their preparation, and uses thereof
03/01/2012WO2012027524A1 A method of inhibiting angiogenesis
03/01/2012WO2012027473A2 Immunogenic compositions comprising alphavirus vectored dengue virus e protein antigens
03/01/2012WO2012027379A2 Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
03/01/2012WO2012027365A2 Targeted multi-epitope dosage forms for induction of an immune response to antigens
03/01/2012WO2012027328A2 Anti-ox40 antibodies and methods of using the same
03/01/2012WO2012027324A2 Treatment for neoplastic diseases
03/01/2012WO2012027017A2 Novel agonists of toll-like receptor 3 and methods of their use
03/01/2012WO2012026878A1 Monoclonal antibody specific to major neutralizing epitope of influenza h5 hemagglutinin
03/01/2012WO2012026832A1 Process of producing shelf stable probiotic food
03/01/2012WO2012026511A1 Pharmaceutical composition
03/01/2012WO2012026508A1 Immunogenic composition
03/01/2012WO2012026309A1 Creation of anti-pad4 antibody pharmaceutical
03/01/2012WO2012025873A2 STABLE FORMULATIONS OF NEISSERIA MENINGITIDIS rLP2086 ANTIGENS
03/01/2012WO2012025603A1 An epstein-barr-virus vaccine
03/01/2012WO2012025551A1 Porous degradable polyelectrolyte microspheres as vaccine vector
03/01/2012WO2012025536A1 Antibodies against il-18r1 and uses thereof
03/01/2012WO2012025167A1 Animal model for the evaluation of the efficacy of an hiv vaccine
03/01/2012WO2012024767A1 Improved enteric active substance delivery
1 ... 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 ... 1823